IBSA USA
Ariel Chi is a highly experienced sales professional currently serving as a Specialty Sales Representative at IBSA Pharma Inc. since April 2022. Prior experience includes roles as a Sales Professional at Amarin Corporation and Account Executive at Sunrise Medical Laboratories. Ariel Chi worked as a Physician Account Executive at Quest Diagnostics and held positions with Publicis Touchpoint Solutions as an Eye Care Educator and GE Sales Representative. Early career experience includes a role as a Professional Sales Specialist and Customer Service Associate with Publicis Touchpoint Solutions. Ariel Chi holds a Bachelor's degree in Finance, International Business, and Spanish from Creighton University's Heider College of Business, with prior education at Millard North High School.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.